Study results suggest immune checkpoint inhibitor therapy may offer immunomodulatory benefits for patients with asthma and ...

Among patients with asthma without diabetes, the risk for exacerbation was decreased with GLP-1 receptor agonist exposure, ...

Asthma is a common prevalent chronic respiratory illness that affects millions of people all over the world in every age group. Asthma is defined as inflamed and constricted airways, causing repeated ...

Asthma biologic use was not associated with an increase in respiratory infection risk, according to results from the 2026 AAAAI Annual Meeting.

The European Commission on Tuesday approved GSK plc’s GSK Exdensur (depemokimab) in two indications, including: As an add-on ...

There’s no cure for childhood asthma, and the condition won’t resolve as a child ages. However, treatments such as inhalers and oral medications can help keep the symptoms under control. Share on ...

Opportunities in the asthma market include the growth driven by innovative therapies like dexpramipexole and depemokimab, expanding patient pools due to rising asthma prevalence, and increased ...

A mother encourages her daughter to fully open her mouth to swallow a live fish holding “the medicine” she believes will help cure her child’s asthma, as scores clamor about, gulping down their own ...

Asthma and COPD share similar breathing symptoms, often leading to confusion and misdiagnosis. Know key differences, risks of ...